ARTICLE

REPORTING ANTIMALARIAL RESISTANCE IN SOUTHEAST ASIA

  1. HOME
  2. ARTICLE

03 Pages : 16-27

http://dx.doi.org/10.31703/giidr.2022(VII-I).03      10.31703/giidr.2022(VII-I).03      Published : Dec 2022

Reporting Antimalarial Resistance in Southeast Asia

Abstract

    Malaria is still on the rise and affecting millions each year. The main reason is the development of resistance against the existing treatments and the requirement of the new regimen. Various areas in Southeast Asia have shown adverse health complications due to drug resistance. The transmission of malaria takes place through the Anopheles mosquito, and it is treated by antimalarial drugs that intercept the parasite’s actions at different stages of its life cycle. Resistance to most drugs occurs due to genomic changes, which help the parasite survive against antimalarial drugs. It can be prevented by timely diagnosis and effective dose surveillance. No vaccine has been developed yet. Whereas newer treatments and approaches are underway.

    Antimalarial, Resistance, Southeast Asia

    (1) Hadia Hussayn
    Undergraduate Student (Pharm D), Department of Pharmacy, Faculty of Biological Sciences, Quaid I Azam University, Islamabad, Pakistan.
    (2) Hina Ayub
    Undergraduate Student (Pharm D), Department of Pharmacy, Faculty of Biological Sciences, Quaid I Azam University, Islamabad, Pakistan.
    (3) Zia Ullah
    Undergraduate Student (Pharm D), Department of Pharmacy, Faculty of Biological Sciences, Quaid I Azam University, Islamabad, Pakistan.
    (4) Gul Shehnaz
    Chairperson, Department of Pharmacy, Faculty of Biological Sciences, Quaid I Azam University, Islamabad, Pakistan.
Fulltext PDF

References

  • Achan, J., Talisuna, A. O., Erhart, A., Yeka, A., Tibenderana, J. K., Baliraine, F. N., D’Alessandro, U. (2011). Quinine, an old antimalarial drug in a modern world: role in the treatment of malaria. Malaria Journal, 10(1), 144.
  • Adagu, i. s., & warhurst, D. C. (1999). Association of cg2 and pfmdr1 genotype with chloroquine resistance in field samples of Plasmodium falciparum from Nigeria. Parasitology 119, 343-348
  • Asih, P. B., Rogers, W. O., Susanti, A. I., Rahmat, A., Rozi, I. E., Kusumaningtyas, M. A., Dewi, R. M., Coutrier, F. N., Sutamihardja, A., van der Ven, A. J., & Sauerwein, R. W. (2009). Seasonal distribution of antimalarial drug resistance alleles on the island of Sumba, Indonesia. Malaria journal, 8(1), pp.1-7.
  • Basco, L. K. (2007). Field application of in vitro assays for the sensitivity of human malaria parasites to antimalarial drugs. Geneva World Health Organization Cop
  • Berens, N., Schwoebel, B., Jordan, S., Vanisaveth, V., Phetsouvanh, R., Christophel, E. M., Phompida, S., Jelinek, T. (2003). Plasmodium falciparum: correlation of in vivo resistance to chloroquine and Antifolate with genetic polymorphisms in isolates from the south of Lao PDR. Trop Med Int Health 8,775–782
  • Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., & Ringwald, P. (2009). Artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine, 361(5), pp.455-467
  • Eckstein-Ludwig, U., Webb, R. J., van Goethem, I. D. A., East, J. M., Lee, A. G., Kimura, M., & Krishna, S. (2003). Artemisinins target the SERCA of Plasmodium falciparum. Nature, 424(6951), 957–961. doi:10.1038/nature01813.
  • Fivelman, Q. L., Butcher, G. A., Adagu, I. S., Warhurst, D. C., & Pasvol, G. (2002). Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. Malaria journal, 1(1), pp.1-4.
  • Gowda, D. C., Dayananda, K., & Achur, R. (2018). Epidemiology, drug resistance, and pathophysiology of Plasmodium vivax malaria. Journal of Vector Borne Diseases, 55(1), p.1)
  • Haldar, K., Bhattacharjee, S., & Safeukui, I. (2018). Drug resistance in Plasmodium. Nature Reviews Microbiology, 16(3), 156–170.
  • Jomaa, H., Wiesner, J., Sanderbrand, S., Altincicek, B., Weidemeyer, C., Hintz, M., Türbachova, I., Eberl, M., Zeidler, J., Lichtenthaler, H. K., & Soldati, D. (1999). Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science, 285(5433), pp.1573-1576.
  • Koenderink, J. B., Kavishe, R. A., Rijpma, S. R., & Russel, F. G. M. (2010). The ABCs of multidrug resistance in malaria. Trends in Parasitology, 26(9), 440–446.
  • Na-Bangchang, K., & Congpuong, K. (2007). Current Malaria Status and Distribution of Drug Resistance in East and Southeast Asia with Special Focus to Thailand. The Tohoku Journal of Experimental Medicine, 211(2), 99–113.
  • Nuno Vale, A., Rui Moreira, b., Paula Gomes. (2009). Primaquine revisited six decades after its discovery. European Journal of Medicinal Chemistry, 44,937–953
  • Organisation Mondiale De La Santé . (2010). Global report on antimalarial drug efficacy and drug resistance: 2000-2010. Geneva: World Health Organization. C.
  • Parija, S., & Praharaj, I. (2011). Drug resistance in malaria. Indian Journal of Medical Microbiology, 29(3), p.243.
  • Price, R. N., Uhlemann, A. C., Brockman, A., McGready, R., Ashley, E., Phaipun, L., & Krishna, S. (2004). Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. The Lancet, 364(9432), 438–447. doi:10.1016/s0140- 6736(04)16767-6.
  • Rathore, D., McCutchan, T. F., Sullivan, M., & Kumar, S. (2005). Antimalarial drugs: current status and new developments. Expert Opinion on Investigational Drugs, 14(7), 871–883. doi:10.1517/13543784.14.7.871
  • Ross, L. S., & Fidock, D. A. (2019). Elucidating Mechanisms of Drug-Resistant Plasmodium falciparum. Cell Host & Microbe, 26(1), 35–47
  • Schlitzer, M. (2008). Antimalarial Drugs – What is in Use and What is in the Pipeline. Archiv Der Pharmazie, 341(3), 149–163.
  • Shibeshi, M. A., Kifle, Z. D., & Atnafie, S. A. (2020). Antimalarial drug resistance and novel targets for antimalarial drug discovery. Infection and Drug Resistance, 13, p.4047.
  • Sumawinata, I. W., Leksana, B., Sutamihardja, A., Subianto, B., Fryauff, D. J., & Baird, J. K. (2003. Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. The American journal of tropical medicine and hygiene, 68(4), pp.416-420.
  • Syafruddin, D., Asih, P. B., Aggarwal, S. L., & Shankar, A. H. (2003). Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Purworejo district, Central Java Province, Indonesia. The American journal of tropical medicine and hygiene, 69(6), pp.614-620.
  • asanor, O., Ruengweerayut, R., Sirichaisinthop, J., Congpuong, K., Wernsdorfer, W. H., & Na- Bangchang, K. (2006). Clinical-parasitological response and in-vitro sensitivity of Plasmodium vivax to chloroquine and quinine on the western border of Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene, 100(5), pp.410-418
  • Uhlemann, A. C., & Krishna, S. (2005). Antimalarial multi- drug resistance in Asia: mechanisms and assessment. Malaria: Drugs, Disease and Post-genomic Biology, pp.39-53.
  • Von Seidlein, L., Duraisingh, M. T., Drakeley, C. J., Bailey, R., Greenwood, B. M., & Pinder, M. (1997).Polymorphism of the Pfmdr1 gene and chloroquine resistance in Plasmodium falciparum in The Gambia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91(4), 450–453. doi:10.1016/s0035- 9203(97)90281-9.
  • White, N. J., Pukrittayakamee, S., Hien, T. T., Faiz, M. A., Mokuolu, O. A., & Dondorp, A. M. (2014). Malaria. The Lancet, 383(9918), 723–735. doi:10.1016/s0140- 6736(13)60024-0
  • White, Nicholas J. (2004). Antimalarial drug resistance. Journal of Clinical Investigation, 113(8), 1084–1092.
  • Wiesner, J., Ortmann, R., Jomaa, H., & Schlitzer, M., (2003). New antimalarial drugs. Angewandte Chemie International Edition, 42(43), pp.5274-5293
  • World Health Organization. (2015). Guidelines for the treatment of malaria. World Health Organization.
  • World Health Organization. Global report on antimalarial drug efficacy and drug resistance: 2000–2010
  • World Health Organization. World Malaria Report 2016 (WHO, 2016
  • Yuthavong, Y. (2002). Basis for antifolate action and resistance in malaria. Microbes and Infection, 4(2), 175–182
  • Zhang, R., Suwanarusk, R., Malleret, B., Cooke, B. M., Nosten, F., Lau, Y. L., Dao, M., Lim, C. T., Renia, L., Tan, K. S. W., & Russell, B. (2016.) A basis for rapid clearance of circulating ring-stage malaria parasites by the spiroindolone KAE609. The Journal of infectious diseases, 213(1), pp.100-104.

Cite this article

APA

CHICAGO

    CHICAGO : Hussayn, Hadia, Hina Ayub, and Zia Ullah. 2022. "Reporting Antimalarial Resistance in Southeast Asia." Global Immunological & Infectious Diseases Review, VII (I): 16-27 doi: 10.31703/giidr.2022(VII-I).03

HARVARD

    HARVARD : HUSSAYN, H., AYUB, H. & ULLAH, Z. 2022. Reporting Antimalarial Resistance in Southeast Asia. Global Immunological & Infectious Diseases Review, VII, 16-27.

MHRA

    MHRA : Hussayn, Hadia, Hina Ayub, and Zia Ullah. 2022. "Reporting Antimalarial Resistance in Southeast Asia." Global Immunological & Infectious Diseases Review, VII: 16-27

MLA

    MLA : Hussayn, Hadia, Hina Ayub, and Zia Ullah. "Reporting Antimalarial Resistance in Southeast Asia." Global Immunological & Infectious Diseases Review, VII.I (2022): 16-27 Print.

OXFORD

    OXFORD : Hussayn, Hadia, Ayub, Hina, and Ullah, Zia (2022), "Reporting Antimalarial Resistance in Southeast Asia", Global Immunological & Infectious Diseases Review, VII (I), 16-27

TURABIAN

    TURABIAN : Hussayn, Hadia, Hina Ayub, and Zia Ullah. "Reporting Antimalarial Resistance in Southeast Asia." Global Immunological & Infectious Diseases Review VII, no. I (2022): 16-27. https://doi.org/10.31703/giidr.2022(VII-I).03